A Review on Antimicrobial Activity of Mushroom (Basidiomycetes) Extracts and Isolated Compounds

Abstract

Despite the huge diversity of antibacterial compounds, bacterial resistance to first-choice antibiotics has been drastically increasing. Moreover, the association between multiresistant microorganisms and nosocomial infections highlight the problem, and the urgent need for solutions. Natural resources have been exploited in the last years and among them, mushrooms could be an alternative source of new antimicrobials. In this review, we present an overview of the antimicrobial properties of mushroom extracts and highlight some of the active compounds identified, including low- and high-molecular weight (LMW and HMW, respectively) compounds. LMW compounds are mainly secondary metabolites, such as sesquiterpenes and other terpenes, steroids, anthraquinones, benzoic acid derivatives, and quinolines, but also primary metabolites such as oxalic acid. HMW compounds are mainly peptides and proteins. Data available from the literature indicate a higher antimicrobial activity of mushroom extracts against gram-positive bacteria. Among all the mushrooms, Lentinus edodes is the most studied species and seems to have a broad antimicrobial action against both gram-postive and gram-negative bacteria. Plectasin peptide, obtained from Pseudoplectania nigrella, is the isolated compound with the highest antimicrobial activity against gram-positive bacteria, while 2-aminoquinoline, isolated from Leucopaxillus albissimus, presents the highest antimicrobial activity against gram-negative bacteria.

Key words

mushrooms - Basidiomycetes - antimicrobials - gram-positive bacteria - gram-negative bacteria

• References

• 1 Bala N, Aitken EAB, Fechner N, Cusack A, Steadman KJ. Evaluation of antibacterial activity of Australian basidiomycetous macrofungi using a high-throughput 96-well plate assay. Pharm Biol 2011; 49: 1-9
• 2 Kalač P. Chemical composition and nutritional value of European species of wild growing mushrooms: A review. Food Chem 2009; 113: 9-16
• 3 Borchers A, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: an update. Exp Biol Med 2004; 229: 393-406
• 4 Lindequist U, Niedermeyer THJ, Jülich WD. The pharmacological potential of mushrooms. eCAM 2005; 2: 285-299
• 5 Poucheret P, Fons F, Rapior S. Biological and pharmacological activity of higher fungi: 20-Year retrospective analysis. Mycologie 2006; 27: 311-333
• 6 Zaidman BZ, Yassin M, Mahajana J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 2005; 67: 453-468
• 7 Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 2007; 7: 701-724
• 8 Zhang M, Cui SW, Cheung PCK, Wang Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 2007; 18: 4-19
• 9 Wasser SP, Weis AL. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: Current perspectives (Review). Int J Med Mushrooms 1999; 1: 31-62
• 10 Beattie KD, Rouf R, Gander L, May TW, Ratkowsky D, Donner CD, Gill M, Grice ID, Tiralongo E. Antibacterial metabolites from Australian macrofungi from the genus Cortinarius . Phytochemistry 2010; 71: 948-955
• 11 Ishikawa NK, Kasuya MCM, Vanetti MCD. Antibacterial activity of Lentinula edodes grown in liquid medium. Braz J Microbiol 2001; 32: 206-210
• 12 Shittu OB, Alofe FV, Onawunmi GO, Ogundaini AO, Tiwalade TA. Mycelial growth and antibacterial metabolite production by wild mushrooms. Afr J Biomed Res 2005; 8: 157-162
• 13 Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Díez MT, García JB, Del Val AG, Gorrochategui J, Hernández P, Peláez F, Vicente MF. Screening of basidiomycetes for antimicrobial activities. Antonie van Leeuwenhoek 2000; 78: 129-139
• 14 Gonçalves O, Pereira R, Gonçalves F, Mendo S, Coimbra MA, Rocha SM. Evaluation of the mutagenicity of sesquiterpenic compounds and their influence on the susceptibility towards antibiotics of two clinically relevant bacterial strains. Mutat Res 2011; 723: 18-25
• 15 Öztürk M, Duru ME, Kivrak S, Mercan-Doğan N, Türkoglu A, Özler MA. In vitro antioxidant, anticholinesterase and antimicrobial activity studies on three Agaricus species with fatty acid compositions and iron contents: a comparative study on the three most edible mushrooms. Food Chem Toxicol 2011; 49: 1353-1360
• 16 Xu X, Yan H, Chen J, Zhang X. Bioactive proteins from mushrooms. Biotechnol Adv 2011; 29: 667-674
• 17 Fuchs FD. Princípios Gerais do Uso de Antimicrobianos. In: Fuchs F, Wannamacher L, Ferreira M, editors Farmacologia Clínica – Fundamentos da terapêutica Racional, 3rd edition. Rio de Janeiro: Guanabara Koogan; 2004: 342
• 18 Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006; 34 (5 Suppl. 1) S3-S10
• 19 Koch AL. Bacterial wall as target for attack: past, present, and future research. Clin Microbiol Rev 2003; 16: 673-687
• 20 Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?. Crit Care Med 1999; 27: 1608-1616
• 21 Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2002; 2: 171-179
• 22 Silveira G, Nome F, Gesser JC, Sá MM, Terenzi H. Estratégias utilizadas no combate a resistência bacteriana. Quím Nova 2006; 29: 3-7
• 23 Craig WA. Antibacterial therapy. In: Goldman & Ausiell, editor Cecil textbook of medicine, 22nd edition. Philadelphia: Saunders; 2004: 1853-1926
• 24 Harbarth S, Harris AD, Carmeli Y, Samore MH. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis 2001; 33: 1462-1468
• 25 Segal-Maurer S, Urban C, Rahal Jr. JJ. Current perspectives on multidrugresistant bacteria. Epidemiology and control. Infect Dis Clin North Am 1996; 10: 939-957
• 26 Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrobiol Agents 2012; 39: 105-114
• 27 WHO. World Health Organization report on infectious diseases 2000 – Overcoming antimicrobial resistance. Available at. http://www.who.int/infectious-disease-report Accessed January 21, 2012
• 28 Peres-Bota D, Rodriguez H, Dimopoulos G, DaRos A, Mélot C, Struelens MJ, Vincent JL. Are infections due to resistant pathogens associated with a worse outcome in critically ill patients?. J Infect 2003; 47: 307-316
• 29 Pittet D. Infection control and quality health care in the new millennium. Am J Infect Control 2005; 33: 258-267
• 30 WHO. World Health Organization report – Antimicrobial resistance (AMR). Available at. http://www.who.int/mediacentre/news/releases/2010/amr_20100820/en/index.html Accessed January 21, 2012
• 31 Barros L, Cruz T, Baptista P, Estevinho LM, Ferreira ICFR. Wild and commercial mushrooms as source of nutrients and nutraceuticals. Food Chem Toxicol 2008; 46: 2742-2747
• 32 Ozen T, Darcan C, Aktop O, Turkekul I. Screening of antioxidant, antimicrobial activities and chemical contents of edible mushrooms wildly grown in the Black Sea region of Turkey. Comb Chem High Throughput Screen 2011; 14: 72-84
• 33 Tambekar DH, Sonar TP, Khodke MV, Khante BS. The novel antibacterials from two edible mushrooms: Agaricus bisporus and Pleurotus sajor caju. Int J Pharmacol 2006; 2: 584-587
• 34 Rosa LH, Machado KMG, Jacob CC, Capelari M, Rosa CA, Zani CL. Screening of Brazilian Basidiomycetes for antimicrobial activity. Mem Inst Oswaldo Cruz 2003; 98: 967-974
• 35 Kalyoncu F, Oskay M, Salam H, Erdogan TF, Tamer AÜ. Antimicrobial and antioxidant activities of mycelia of 10 wild mushroom species. J Med Food 2010; 13: 415-419
• 36 Kalyoncu F, Oskay M. Antimicrobial activities of four wild mushroom species collected from Turkey. Proceeding of the 6th International Conference on Mushroom Biology and Mushroom Products, 2008. Krefeld, Germany: J.I. LelleyGAMU GmbH, Institut für Pilzforschung; 2008
• 37 Barros L, Venturini BA, Baptista P, Estevinho LM, Ferreira ICFR. Chemical composition and biological properties of Portuguese wild mushrooms: a comprehensive study. J Agric Food Chem 2008; 56: 3856-3862
• 38 Solak MH, Kalmis E, Saglam H, Kalyoncu F. Antimicrobial activity of two wild mushrooms Clitocybe alexandri (Gill.) Konr. and Rhizopogon roseolus (Corda) T.M. Fries collected from Turkey. Phytother Res 2006; 20: 1085-1087
• 39 Quereshi S, Pandey AK, Sandhu SS. Evaluation of antibacterial activity of different Ganoderma lucidum extracts. J Sci Res 2010; 3: 9-13
• 40 Sheena N, Ajith TA, Mathew AT, Janardhanan KK. Antibacterial activity of three macrofungi, Ganoderma lucidum, Navesporus floccosa and Phellinus rimosus occurring in South India. Pharm Biol 2003; 41: 564-567
• 41 Gao Y, Tang W, Gao H, Chan E, Lan J, Li X, Zhou S. Antimicrobial activity of the medicinal mushroom Ganoderma . Food Rev Int 2005; 21: 211-229
• 42 Smânia A, Monache FD, Smânia EFA, Gil ML, Benchetrit LC, Cruz FS. Antibacterial activity of a substance produced by the fungus Pycnoporus sanguineus (Fr.) Murr. J Ethnopharmacol 1995; 45: 177-181
• 43 Smânia EFA, Smânia A, Loguercio-Leite C, Gil ML. Optimal parameters for cinnabarin synthesis by Pycnoporus sanguineus . J Chem Technol Biotechnol 1997; 70: 57-59
• 44 Yamac M, Bilgili F. Antimicrobial activities of fruit bodies and/or mycelial cultures of some mushroom isolates. Pharm Biol 2006; 44: 660-667
• 45 Barros L, Calhelha RC, Vaz JA, Ferreira ICFR, Baptista P, Estevinho LM. Antimicrobial activity and bioactive compounds of Portuguese wild edible mushrooms methanolic extracts. Eur Food Res Technol 2007; 225: 151-156
• 46 Barros L, Baptista P, Estevinho LM, Ferreira ICFR. Effect of fruiting body maturity stage on chemical composition and antimicrobial activity of Lactarius sp. mushrooms. J Agric Food Chem 2007; 55: 8766-8771
• 47 Gezer K, Duru ME, Kivrak I, Turkoglu A, Mercan N, Turkoglu H, Gulcan S. Free-radical scavenging capacity and antimicrobial activity of wild edible mushroom from Turkey. Afr J Biotechnol 2006; 5: 1924-1928
• 48 Turkoglu A, Duru ME, Mercan N, Kivrak I, Gezer K. Antioxidant and antimicrobial activities of Laetiporus sulphureus (Bull.) Murrill. Food Chem 2007; 101: 267-273
• 49 Dulger B, Ergul CC, Gucin F. Antimicrobial activity of the macrofungus Lepista nuda . Fitoterapia 2002; 73: 695-697
• 50 Hearst R, Nelson D, McCollum G, Millar BC, Maeda Y, Goldsmith CE, Rooney PJ, Loughrey A, Rao JR, Moore JE. An examination of antibacterial and antifungal properties of constituents of Shiitake (Lentinula edodes) and Oyster (Pleurotus ostreatus) mushrooms. Complement Ther Clin Pract 2009; 15: 5-7
• 51 Hur JM, Yang CH, Han SH, Lee SH, You YO, Park -C Kim KJ. Antibacterial effect of Phellinus linteus against methicillin-resistant Staphylococcus aureus . Fitoterapia 2004; 75: 603-605
• 52 Hatvani N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int J Antimicrob Agents 2001; 17: 71-74
• 53 Signoretto C, Burlacchini G, Marchi A, Grillenzoni M, Cavalleri G, Ciric L, Lingström P, Pezzati E, Daglia M, Zaura E, Pratten J, Spratt DA, Wilson M, Canepari P. Testing a low molecular mass fraction of a mushroom (Lentinus edodes) extract formulated as an oral rinse in a cohort of volunteers. J Biomed Biotechnol advance online publication 2011;
• 54 Hirasawa M, Shouji N, Neta T, Fukushima K, Takada K. Three kinds of antibacterial substances from Lentinus edodes (Berk.) Sing. (Shiitake, an edible mushroom). Int J Antimicrob Agents 1999; 11: 151-157
• 55 Barros L, Baptista P, Estevinho LM, Ferreira ICFR. Bioactive properties of the medicinal mushroom Leucopaxillus giganteus mycelium obtained in the presence of different nitrogen sources. Food Chem 2007; 105: 179-186
• 56 Liu XT, Winkler AL, Schwan WR, Volk TJ, Rott MA, Monte A. Antibacterial compounds from mushrooms I: a lanostane-type triterpene and prenylphenol derivates from Jahnoporus hiritus and Albatrellus flettii and their activities against Bacillus cereus and Enterococcus faecalis . Planta Med 2010; 76: 182-185
• 57 Mothana RAA, Jansen R, Jülich WD, Lindequist U. Ganomycins A and B, new antimicrobial Farnesyl hydroquinones from the Basidiomycete Ganoderma pfeifferi . J Nat Prod 2000; 63: 416-418
• 58 Ishikawa NK, Fukushi Y, Yamaji K, Tahara S, Takahashi K. Antimicrobial cuparene-type sesquiterpenes, enokipodins C and D, from a mycelial culture of Flammulina velutipes . J Nat Prod 2001; 64: 932-934
• 59 Bender S, Dumitrache CN, Backhaus J, Christie G, Cross RF, Lonergan GT, Baker WL. A case for caution in assessing the antibiotic activity of extracts of culinary-medicinal Shiitake mushroom [Lentinus edodes (Berk.) Singer] (Agaricomycetideae). Int J Med Mushrooms 2003; 5: 31-35
• 60 Quang DN, Bach DD, Hashimoto T, Asakawa Y. Chemical constituents of the Vietnamese inedible mushroom Xylaria intracolorata . Nat Prod Res 2006; 20: 317-321
• 61 Zheng H, Maoqing Y, Liqiu X, Wenjuan T, Lian L, Guolin Z. Purification and characterization of an antibacterial protein from the cultured mycelia of Cordyceps sinensis . Wuhan Univ J Nat Sci 2006; 11: 709-714
• 62 Ngai PHK, Ng TB. A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju . Peptides 2004; 25: 11-17
• 63 Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sönksen CP, Ludvigsen S, Raventós D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jørgensen SG, Sørensen MV, Christensen BE, Kjærulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungu. Nature 2005; 437: 975-980
• 64 Lee SJ, Yeo WH, Yun S, Yoo D. Isolation and sequence analysis of new peptaibol, boletusin, from Boletus spp. J Pept Sci 1999; 5: 374-378
• 65 Yoon SY, Eo SK, Kim YS, Lee CK, Han SS. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res 1994; 17: 438-442
• 66 Anke T, Kupka J, Schramm G, Steglich W. Antibiotics from basidiomycetes. X. Scorodonin, a new antibacterial and antifungal metabolite from Marasmius scorononius (Fr.). J Antibiot 1980; 33: 463-467
• 67 Ciric L, Tymon A, Zaura E, Lingström P, Stauder M, Papetti A, Signoretto C, Pratten J, Wilson M, Spratt D. In vitro assessment of Shiitake mushroom (Lentinula edodes) extract for its antigingivitis activity. J Biomed Biotechnol advance online publication 2011;
• 68 Signoretto C, Marchi A, Bertoncelli A, Burlacchini G, Tessarolo F, Caola I, Pezzati E, Zaura E, Papetti A, Lingström P, Pratten J, Spratt DA, Wilson M, Canepari P. Effects of mushroom and chicory extracts on the physiology and shape of Prevotella intermedia, a periodontopathogenic bacterium. J Biomed Biotechnol advance online publication 2011;
• 69 SchwanWR. Dunek C, Gebhardt M, Engelbrecht K, Klett T, Monte A, Toce J, Rott M, Volk TJ, LiPuma JJ, Liu XT, McKelvey R. Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity. Ann Clin Microb Antimicrob 2010; 9: 4
• 70 Zheng S, Liu Q, Zhang G, Wang H, Ng TB. Purification and characterization of an antibacterial protein from dried fruiting bodies of the wild mushroom Clitocybe sinopica . Acta Biochim Pol 2010; 51: 43-48
• 71 Nicholas GM, Blunt JW, Munro MHG. Cortamidine oxide, a novel disulfide metabolite from the New Zealand basidiomycete (mushroom) Cortinarius species. J Nat Prod 2001; 64: 341-344